GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Equity-to-Asset

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Equity-to-Asset

: 0.00 (As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Carl Zeiss Meditec AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $0 Mil. Carl Zeiss Meditec AG's Total Assets for the quarter that ended in Dec. 2023 was $0 Mil.

The historical rank and industry rank for Carl Zeiss Meditec AG's Equity-to-Asset or its related term are showing as below:

CZMWF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.63   Med: 0.69   Max: 0.79
Current: 0.71

During the past 13 years, the highest Equity to Asset Ratio of Carl Zeiss Meditec AG was 0.79. The lowest was 0.63. And the median was 0.69.

CZMWF's Equity-to-Asset is ranked better than
58.9% of 871 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs CZMWF: 0.71

Carl Zeiss Meditec AG Equity-to-Asset Historical Data

The historical data trend for Carl Zeiss Meditec AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Equity-to-Asset
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.71 0.69 0.71 0.71

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.72 - 0.71 -

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG Equity-to-Asset Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Equity-to-Asset falls into.



Carl Zeiss Meditec AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Carl Zeiss Meditec AG's Equity to Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Equity to Asset (A: Sep. 2023 )=Total Stockholders Equity/Total Assets
=2304.646/3236.845
=0.71

Carl Zeiss Meditec AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Carl Zeiss Meditec AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.